Skip to main content
. 2021 Aug 10;12(4):e01458-21. doi: 10.1128/mBio.01458-21

FIG 1.

FIG 1

Miltefosine is a potential new anti-aspergillosis compound and shows its interaction with the sphingolipid inhibitor myriocin. (A) Screening of chemical libraries reveals potential new anti-aspergillosis compounds. (B) Interaction between miltefosine and posaconazole. (C) Interaction between miltefosine and voriconazole. (D) Interaction between miltefosine and amphotericin B. (E) Interaction between miltefosine and caspofungin. (F) Interaction between miltefosine and myriocin.